Clinical trial
Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing…
NCT00238342 · Gynecologic Oncology Group, Other · Unknown status
Key facts
| NCT number | NCT00238342 |
|---|---|
| Title | Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass |
| Official title | Pelvic Mass Study to Develop Serum Proteomic Profiles (SIGNATURES) for Epithelial Ovarian Cancer Diagnosis and Prognosis |
| Lead sponsor | Gynecologic Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Fallopian Tube Cancer, Ovarian Cancer |
| Intervention type | Genetic, Other, Procedure |
| Interventions | proteomic profiling, surface-enhanced laser desorption/ionization-time of flight mass spectrometry, biopsy |
| Enrollment | 2,000 |
| Start date | Oct 1, 2005 |
| Primary completion | Oct 1, 2007 |
| First posted | Oct 13, 2005 |
| Last update posted | Feb 9, 2010 |
| Countries | United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: